Table of Contents
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 Peripheral Nerve Stimulators (PNS) Overview 4
3 Products under Development 5
3.1 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Stage of Development 5
3.2 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Territory 6
3.3 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Regulatory Path 7
3.4 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Estimated Approval Date 8
3.5 Peripheral Nerve Stimulators (PNS) – Ongoing Clinical Trials 9
4 Peripheral Nerve Stimulators (PNS) – Pipeline Products under Development by Companies 10
4.1 Peripheral Nerve Stimulators (PNS) Companies – Pipeline Products by Stage of Development 10
4.2 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Stage of Development 11
5 Peripheral Nerve Stimulators (PNS) Companies and Product Overview 12
5.1 Actuated Medical Inc Company Overview 12
5.1.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 Cardionomic Inc (Inactive) Company Overview 13
5.2.1 Cardionomic Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 13
5.3 Checkpoint Surgical Inc Company Overview 14
5.3.1 Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.4 EMKinetics, Inc. Company Overview 15
5.4.1 EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.5 Epineuron Technologies Inc Company Overview 18
5.5.1 Epineuron Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Gondola Medical Technologies SA Company Overview 19
5.6.1 Gondola Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 Remedee Labs SAS Company Overview 22
5.7.1 Remedee Labs SAS Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 Washington University School of Medicine Company Overview 25
5.8.1 Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 25
6 Peripheral Nerve Stimulators (PNS)- Recent Developments 26
6.1 Nov 13, 2019: Remedee Labs Breakthrough Endorphin Stimulation Solution Is Unveiled 26
6.2 Nov 13, 2019: New clinical trial into pain management started by leading French research hospital 26
6.3 Sep 23, 2019: Cala Health announces positive topline data from landmark PROSPECT study for essential tremor (ET) 26
6.4 Aug 21, 2019: SPR Therapeutics SPRINT Peripheral Nerve Stimulation System significantly reduces opioid use in patients with low back pain, interim data show 27
6.5 Apr 08, 2019: Study of SPR Therapeutics Peripheral Nerve Stimulation System demonstrates significant and sustained relief of post-amputation pain 28
6.6 Jan 17, 2019: Cala Health enrolls first patients in landmark PROSPECT study for essential tremor 29
6.7 Jan 15, 2019: SPR Therapeutics names Dr. Peter Staats as Chief Medical Advisor 30
7 Appendix 31
7.1 Methodology 31
7.2 About GlobalData 34
7.3 Contact Us 34
7.4 Disclaimer 34
Table 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 5
Table 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory 6
Table 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path 7
Table 4: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date 8
Table 5: Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials 9
Table 6: Peripheral Nerve Stimulators (PNS) Companies - Pipeline Products by Stage of Development 10
Table 7: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 11
Table 8: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 12
Table 9: Peripheral Nerve Targeting System - Product Status 12
Table 10: Peripheral Nerve Targeting System - Product Description 12
Table 11: Cardionomic Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 13
Table 12: Neurostimulator - Cardiac Contractility - Product Status 13
Table 13: Neurostimulator - Cardiac Contractility - Product Description 13
Table 14: Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 15: Checkpoint BEST System - Product Status 14
Table 16: Checkpoint BEST System - Product Description 14
Table 17: EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 18: TranStim Transdermal Neuromodulation System - Product Status 15
Table 19: TranStim Transdermal Neuromodulation System - Product Description 15
Table 20: EMKinetics, Inc. - Ongoing Clinical Trials Overview 16
Table 21: TranStim Transdermal Neuromodulation System - Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home 17
Table 22: Epineuron Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 23: Wearable Device - Peripheral Nerve Stimulation - Product Status 18
Table 24: Wearable Device - Peripheral Nerve Stimulation - Product Description 18
Table 25: Gondola Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 19
Table 26: Gondola Device - Product Status 19
Table 27: Gondola Device - Product Description 19
Table 28: Gondola Medical Technologies SA - Ongoing Clinical Trials Overview 20
Table 29: Gondola Device - Multi-center, Double-blind, Cross-over Randomized Study on the Use of the Medical Device Gondola for Motor Rehabilitation in Patients with Parkinson's Disease 21
Table 30: Remedee Labs SAS Pipeline Products & Ongoing Clinical Trials Overview 22
Table 31: Endorphin-Stimulation Device - Product Status 22
Table 32: Endorphin-Stimulation Device - Product Description 22
Table 33: Remedee Labs SAS - Ongoing Clinical Trials Overview 23
Table 34: Endorphin-Stimulation Device - Innovative Device for Pain Management by Millimeter Band Radiation: Electronic-Pain Killer: First in Human Evaluation in Perioperative with Regard to a Control Group 24
Table 35: Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 25
Table 36: Biodegradable Device - Electrical Stimulation - Product Status 25
Table 37: Biodegradable Device - Electrical Stimulation - Product Description 25
Table 38: Glossary 33
List of Figures
Figure 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 5
Figure 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory 6
Figure 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path 7
Figure 4: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date 8
Figure 5: Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials 9
【免責事項】
https://www.marketreport.jp/reports-disclaimer